Photo Rounds

Generalized pruritic blisters and bullous lesions

Author and Disclosure Information

In a patient with no history of skin disease, a recent change provided a clue to his condition.


 

References

A 62-year-old man presented to our skin clinic with multiple pruritic, tense, bullous lesions that manifested on his arms, abdomen, back, and upper thighs over a 1-month period. There were no lesions in his oral cavity or around his eyes, nose, or penile region. He denied dysphagia.

The patient had multiple comorbidities, including diabetes, hypertension, recent stroke, and end-stage renal disease. He was being prepared for dialysis. His medications included torsemide, warfarin, amiodarone, metoprolol, pantoprozole, atorvastatin, and nifedipine. About 3 months prior to this presentation, he was started on oral linaglipton 5 mg/d, an oral antihyperglycemic medication. He had no history of skin disease or cancer, and his family history was not significant.

Physical examination showed multiple 5-mm to 2-cm blisters and bullae on the flexural surface of both of his arms (FIGURE), back, lower abdomen, and upper thighs. His palms and soles were not involved. The lesions were nontender, tense, and filled with clear fluid. Some were intact and others were rupturing. There was no mucocutaneous involvement. Nikolsky sign was negative. There were no signs of bleeding.

Intact tense bullae

The family physician (FP) obtained a 4-mm punch biopsy at the edge of a 6-mm blister for light microscopy and a 3-mm perilesional punch biopsy for direct immunofluorescence (DIF) microscopy.

WHAT IS YOUR DIAGNOSIS?
HOW WOULD YOU TREAT THIS PATIENT?

Pages

Recommended Reading

Large study links brown fat with lower rates of cardiometabolic disease
MDedge Family Medicine
Another lot of extended-release metformin is recalled in the U.S.
MDedge Family Medicine
Endocrine Society calls for action to reduce insulin costs
MDedge Family Medicine
To fast or not? The new dieting dilemma
MDedge Family Medicine
Pressure builds on CDC to prioritize both diabetes types for vaccine
MDedge Family Medicine
Biomarker HF risk score envisioned as SGLT2 inhibitor lodestar in diabetes
MDedge Family Medicine
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
MDedge Family Medicine
Low-carb diets boost diabetes remission rates, at least short term
MDedge Family Medicine
Tactics to prevent or slow progression of CKD in patients with diabetes
MDedge Family Medicine
Can viscous fiber lower glycemic markers in type 2 diabetes?
MDedge Family Medicine